Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Stem Cell Reviews and Reports|May 20, 2020
Mechanistic Basis of ex Vivo Umbilical Cord Blood Stem Progenitor Cell ExpansionR Alejandro Sica, Meryem K Terzioglu, Dolores Mahmud, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Cord blood nucleated cells induce delayed T cell alloreactivitySandeep Chunduri, Dolores Mahmud, Javaneh Abbasian, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2003
Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cellsShahab Uddin, Jeong Ah-Kang, Jodie Ulaszek, et al.
American Journal of Blood Research|April 13, 2016
Clinical grade isolation of regulatory T cells from G-CSF mobilized peripheral blood improves with initial depletion of monocytesPritesh Patel, Dolores Mahmud, Youngmin Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Human CD4(+)CD25(+) Cells in Combination with CD34(+) Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell AlloreactivityDolores Mahmud, Benedetta Nicolini, Lennert van den Dries, et al.
Stem Cells (Dayton, Ohio)|December 13, 2025
Valproic acid-expanded cord blood CD34+CD90+ cells are functionally distinct based on their originAl Rabee Kassis, Amudha Ganapathy, Amal Mechaal, et al.
Biochemical and Biophysical Research Communications|October 3, 2002
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathwayMaaza G-Amlak, Shahab Uddin, Dolores Mahmud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2019
Chromatin-Modifying Agent-Expanded Human Cord Blood Cells Display Reduced Allostimulatory CapacityBenjamin Petro, Dolores Mahmud, Simona Taioli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2019
Synergistic Cytotoxic Effect of Busulfan and the PARP Inhibitor Veliparib in Myeloproliferative NeoplasmsPritesh R Patel, Vitalyi Senyuk, Natalie S Rodriguez, et al.
Pageof 2